Topotarget logo
Media | Contact | Disclaimer | Careers
  • About us
    • Vision & Mission
    • Goal & Strategy
    • Values
    • Board of Directors
    • Management
    • Business Development
  • Oncology
    • Cancer at a glance
  • Belinostat
    • Mode of action
    • Clinical use
    • Safety profile
    • Indications and clinical program
    • Belinostat clinical studies
    • NCI- and Investigator Sponsored Trials
    • Belinostat abstracts - ASCO 2013
  • Science
    • Histone Deacetylase (HDAC)
    • Scientific publications
    • Glossary
  • Collaborators
    • Academic collaborators
    • Partners
  • Investor
About us
  • Vision & Mission
  • Goal & Strategy
  • Values
  • Board of Directors
  • Management
    • Anders Fink Vadsholt
    • Elisabeth V. Carstensen
    • Anne V. Sillemann
    • Jette Tjørnelund
    • Lone Dahl
  • Business Development

Management

Anders Fink Vadsholt Chief Executive Officer
Elisabeth V. Carstensen Director of Pharmaceutical Operations
Anne V. Sillemann Director of Global Regulatory Affairs
Jette Tjørnelund Director of Science
Lone Dahl Director of Finance